Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ 79,847
▼ 18% vs 2024
Profit
Caution€ -20,694
▼ 268% vs 2024
Debts
Normal€ 447,287
▼ 6% vs 2024
EZI Biolab from Oupeye, company number BE0500516337, closed financial year 2025 with a result of € -20,694 after tax. For that financial year EZI Biolab recorded a gross margin of € 79,847 and equity of € 152,455. Compared with financial year 2024, the result moved from € -5,617 to € -20,694. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.
What happened at EZI Biolab?
What happened at EZI Biolab in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 20,694. Source: NBB ↗
- Isabelle MOURAD became a director. NBB
- Etienne CAVALIER became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Ans. KBO
In short
From € 15,860 profit in 2021 to € 20,694 loss in 2025.
Paid € 2,318 in corporate taxes since 2021.
Best year ever: 2021, with € 15,860 profit.
Paid out € 3,000 in dividends to the owners in total.
A new publication or filing at EZI Biolab? We notify you, reason included.
Follow EZI BiolabNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind EZI Biolab are Isabelle MOURAD and Etienne CAVALIER. The same people are also behind European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
Directors
According to the 2025 annual accounts
Isabelle MOURAD
Director
since 2021
Etienne CAVALIER
Director
Also active at: European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
since 2021
Establishments
Establishment units
Physical locations of this company
Rue du Broux 37
4680 Oupeye
Avenue de l'Energie 31 box 20
4432 Ans
Active since 22 October 2012
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0500.516.337
- VAT number
- BE 0500.516.337
- Registered office
- Rue du Broux 37, 4680 Oupeye
- Names & denominations
- EZI Biolab · EZI Consult
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 November 2012
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Groothandel in parfumerieën en cosmetica
Groothandel in farmaceutische en medische artikelen
Organisatie van congressen en beurzen
Overige vormen van onderwijs
Overige zakelijke dienstverlening, neg